| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |